M1 Kliniken announces change in the Management Board and confirms long-term
growth strategy

EQS-News: M1 Kliniken AG / Key word(s): Personnel
M1 Kliniken announces change in the Management Board and confirms long-term
growth strategy

11.06.2024 / 16:38 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

M1 Kliniken announces change in the Management Board and confirms long-term
growth strategy

Berlin, 11 June 2024 - Kilian Brenske, member of the Management Board since
2022, has asked the Supervisory Board to terminate his position on the
Management Board for private reasons. The areas of national and
international expansion, marketing, purchasing and sales, which he was
previously responsible for together with Co-CEO Attila Strauss, will in
future be managed by Attila Strauss alone.

Uwe Zimdars, Chairman of the Supervisory Board of M1 Kliniken AG, comments:
'The Supervisory Board would like to thank Kilian Brenske for his many years
of service to the company, his commitment to M1 Kliniken and the
consistently good and trusting cooperation. We deeply regret that Mr Brenske
has decided to step down from his position for personal reasons.'

Attila Strauss emphasises the ambitious growth targets of M1 Kliniken: 'We
have been able to significantly increase sales and profits since 2022. In
the first quarter of 2024, Group EBIT rose by 70% to EUR 6.8 million and we
are also very satisfied with the performance of the second quarter of 2024
to date. Sales of between EUR 80 million and EUR 90 million and EBIT of
between EUR 18 million and EUR 22 million are expected for the Beauty
segment in the current financial year. By 2029, the company plans to achieve
sales of EUR 200 to 300 million in the Beauty segment with an EBIT margin of
at least 20%.'


About M1 Kliniken AG

M1 Kliniken AG is the leading fully integrated provider of aesthetic medical
healthcare services in Europe. The Group offers products and services of the
highest quality standards in the aesthetic and surgical fields. Beauty
medical treatments are currently offered at 61 specialist centres under the
'M1 Med Beauty' brand. With six operating rooms and 35 beds, the 'M1
Schlossklinik' for Plastic and Aesthetic Surgery in Berlin is one of the
largest and most modern facilities of its kind in Europe. M1 Kliniken has
been driving forward its internationalisation since the end of 2018 and is
currently represented in ten countries.


Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M: ir@m1-kliniken.de


---------------------------------------------------------------------------

11.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        M1 Kliniken AG
                   Grünauer Straße 5
                   12557 Berlin
                   Germany
   Phone:          +49 (0)30 347 47 44 14
   Fax:            +49 (0)30 347 47 44 17
   E-mail:         ir@m1-kliniken.de
   Internet:       https://www.m1-kliniken.de
   ISIN:           DE000A0STSQ8
   WKN:            A0STSQ
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Frankfurt (Basic Board), Hamburg, Hanover, Munich,
                   Stuttgart, Tradegate Exchange
   EQS News ID:    1922875

End of News EQS News Service
---------------------------------------------------------------------------

1922875 11.06.2024 CET/CEST